| HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ a Petr URBÁNEK. The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. In Hepatitis C 3rd International Conference The third decade ad beyond. 2009. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{840089,
author = {Husa, Petr and Oltman, Marián and Ivanovski, Ljubomir and Řehák, Vratislav and Gribajcevic, Mehmed and Messinger, Diethelm and Tietz, Andreas and Urbánek, Petr},
booktitle = {Hepatitis C 3rd International Conference The third decade ad beyond.},
language = {eng},
title = {The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe.},
year = {2009}
}
TY - CONF
ID - 840089
AU - Husa, Petr - Oltman, Marián - Ivanovski, Ljubomir - Řehák, Vratislav - Gribajcevic, Mehmed - Messinger, Diethelm - Tietz, Andreas - Urbánek, Petr
PY - 2009
TI - The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe.
ER -
HUSA, Petr, Marián OLTMAN, Ljubomir IVANOVSKI, Vratislav ŘEHÁK, Mehmed GRIBAJCEVIC, Diethelm MESSINGER, Andreas TIETZ a Petr URBÁNEK. The efficacy of peginterferon alfa-2a (40 kD) in treatment-experinced patients with genotype 1 HCV: results from an opel-label, expanded access programme in Eastern Europe. In \textit{Hepatitis C 3rd International Conference The third decade ad beyond.}. 2009.
|
